Plasma Endocannabinoid Levels in Patients with Borderline Personality Disorder and Healthy Controls

Plasma Endocannabinoid Levels in Patients with Borderline Personality Disorder and Healthy Controls

Borderline personality disorder (BPD) is a highly prevalent psychiatric disorder and presents a complex therapeutic challenge due to limited treatment modalities. Recent focus has converged on the endocannabinoid system (ECS) as a prospective modulator of psychopathological processes in BPD. To addr...

Full description

Bibliographic Details
Main Authors: Jennifer Spohrs, Valentin Kühnle, David Mikusky, Niklas Sanhüter, Ana Macchia, Sandra Nickel, Birgit Abler
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:International Journal of Molecular Sciences
Subjects:
borderline personality disorder
endocannabinoid system
anandamide
<i>FAAH</i> rs324420
depression
Online Access:https://www.mdpi.com/1422-0067/24/24/17452

Internet

https://www.mdpi.com/1422-0067/24/24/17452

Similar Items